SCHEMBL5316304

SCHEMBL5316304

CC(Cc1cc(Cl)cc(C#N)c1)Nc1nccc(N(C)c2ccnc(-c3ccccc3)n2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK4 Q9HAZ1 4/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ CYP3A4 P08684 3/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ CYP2C19 P33261 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ USP2 O75604 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ MAPK14 Q16539 10/20 0.36
▸ LMNA P02545 2/20 0.36
▸ ABCG2 Q9UNQ0 2/20 0.35
▸ AURKA O14965 1/20 0.34
▸ DYRK1A Q13627 1/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ ABCC1 P33527 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914244 0.88 CLK4 (0.46) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5914240 0.88 CLK4 (0.46) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5914185 0.84 CLK4 (0.39) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5262307 0.84 CLK4 (0.39) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5913924 0.81 CLK4 (0.43) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5913917 0.81 CLK4 (0.43) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5913862 0.78 CFD (0.39) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL5914160 0.76 AURKA (0.36) MAPK14AURKACDK4
SCHEMBL5914416 0.76 MAPK14 (0.40) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5914418 0.76 MAPK14 (0.40) CLK4CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 — — EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 — — WO disclosed
Send feedback